secwatch.observer — SEC 8-K summary
======================================

Issuer:     Foghorn Therapeutics Inc. (FHTX)
CIK:        0001822462
Form:       8-K
Filed at:   2024-05-20T23:59:59+00:00
Accession:  0001628280-24-024217
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Foghorn Therapeutics files investor presentation; no specific facts available in filing text
--------------------------------------------------------------------------------

- Form 8-K furnished under Item 7.01; presentation dated May 20, 2024.
- Presentation tagged 'Unique biology, Precision therapeutics, Broad impact'.
- No quantitative data, pipeline updates, or financial guidance provided in the filing.
- Presentation available as Exhibit 99.1 but its content is not extracted in this filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822462/000162828024024217/0001628280-24-024217-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822462/000162828024024217/fhtx-20240520.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-024217

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer